rs2289656
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006180.6(NTRK2):c.1937+13G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.168 in 1,612,644 control chromosomes in the GnomAD database, including 24,178 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1953 hom., cov: 32)
Exomes 𝑓: 0.17 ( 22225 hom. )
Consequence
NTRK2
NM_006180.6 intron
NM_006180.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.26
Publications
36 publications found
Genes affected
NTRK2 (HGNC:8032): (neurotrophic receptor tyrosine kinase 2) This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
NTRK2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 58Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- obesity, hyperphagia, and developmental delayInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 9-84948647-G-A is Benign according to our data. Variant chr9-84948647-G-A is described in ClinVar as Benign. ClinVar VariationId is 1249612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NTRK2 | NM_006180.6 | c.1937+13G>A | intron_variant | Intron 16 of 18 | ENST00000277120.8 | NP_006171.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.153 AC: 23329AN: 152072Hom.: 1956 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
23329
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.150 AC: 37451AN: 249854 AF XY: 0.151 show subpopulations
GnomAD2 exomes
AF:
AC:
37451
AN:
249854
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.170 AC: 247774AN: 1460454Hom.: 22225 Cov.: 33 AF XY: 0.169 AC XY: 122517AN XY: 726502 show subpopulations
GnomAD4 exome
AF:
AC:
247774
AN:
1460454
Hom.:
Cov.:
33
AF XY:
AC XY:
122517
AN XY:
726502
show subpopulations
African (AFR)
AF:
AC:
3643
AN:
33464
American (AMR)
AF:
AC:
5668
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
AC:
6337
AN:
26134
East Asian (EAS)
AF:
AC:
1500
AN:
39694
South Asian (SAS)
AF:
AC:
8877
AN:
86168
European-Finnish (FIN)
AF:
AC:
8619
AN:
53368
Middle Eastern (MID)
AF:
AC:
1269
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
201931
AN:
1110856
Other (OTH)
AF:
AC:
9930
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
10077
20155
30232
40310
50387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6910
13820
20730
27640
34550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.153 AC: 23328AN: 152190Hom.: 1953 Cov.: 32 AF XY: 0.151 AC XY: 11241AN XY: 74392 show subpopulations
GnomAD4 genome
AF:
AC:
23328
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
11241
AN XY:
74392
show subpopulations
African (AFR)
AF:
AC:
4602
AN:
41524
American (AMR)
AF:
AC:
2257
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
860
AN:
3470
East Asian (EAS)
AF:
AC:
183
AN:
5176
South Asian (SAS)
AF:
AC:
441
AN:
4816
European-Finnish (FIN)
AF:
AC:
1812
AN:
10596
Middle Eastern (MID)
AF:
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12593
AN:
67992
Other (OTH)
AF:
AC:
346
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1011
2022
3033
4044
5055
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
319
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Sep 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 58 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Obesity, hyperphagia, and developmental delay Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.